Index by Author

September 1983; 6 (5)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abourizk, N

    • Diabetes mellitus and thyroid disease. Diabetes Care September 1983 6:512-520; doi:10.2337/diacare.6.5.512

  2. Alberti, K G

    • The oral glucose tolerance test (OGTT): effect of rate of ingestion of carbohydrate and different carbohydrate preparations. Diabetes Care September 1983 6:441-445; doi:10.2337/diacare.6.5.441

B

  1. Bantle, J P

    • Urinary C-peptide as a measure of beta-cell function after a mixed meal in healthy subjects: comparison of four-hour urine C-peptide with serum insulin and plasma C-peptide. Diabetes Care September 1983 6:488-492; doi:10.2337/diacare.6.5.488

  2. Barbosa, J

    • Dear ol' mom. Diabetes Care September 1983 6:526-527

  3. Barbosa, J J

    • Urinary C-peptide as a measure of beta-cell function after a mixed meal in healthy subjects: comparison of four-hour urine C-peptide with serum insulin and plasma C-peptide. Diabetes Care September 1983 6:488-492; doi:10.2337/diacare.6.5.488

  4. Barklind, A

    • Dear ol' mom. Diabetes Care September 1983 6:526-527

  5. Beckett, A G

    • Diarrhea and metformin in a diabetic clinic. Diabetes Care September 1983 6:472-474; doi:10.2337/diacare.6.5.472

  6. Behar, J

    • A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care September 1983 6:463-467; doi:10.2337/diacare.6.5.463

  7. Bending, J J

    • Meeting the problems of first-generation insulin infusion pumps: clinical trial of a new miniature infuser. Diabetes Care September 1983 6:452-458; doi:10.2337/diacare.6.5.452

  8. Birtwell, A J

    • Glycosylated serum albumin: an intermediate index of diabetic control. Diabetes Care September 1983 6:501-503; doi:10.2337/diacare.6.5.501

C

  1. Chu, C P

    • Sources of disparity in the spectrum of diabetes mellitus at incidence and prevalence. Diabetes Care September 1983 6:427-431; doi:10.2337/diacare.6.5.427

  2. Cohen, S J

    • Potential barriers to diabetes care. Diabetes Care September 1983 6:499-500; doi:10.2337/diacare.6.5.499

D

  1. Dandona, P

    • Diarrhea and metformin in a diabetic clinic. Diabetes Care September 1983 6:472-474; doi:10.2337/diacare.6.5.472

  2. Davis, R E

    • Hemoglobinopathy in patients with diabetes mellitus: a complicating factor in the measurement of glycosylated hemoglobin. Diabetes Care September 1983 6:524

  3. DeMarais, R

    • The glycemic effect of different meals approximately isocaloric and similar in protein, carbohydrate, and fat content as calculated using the ADA exchange lists. Diabetes Care September 1983 6:432-435; doi:10.2337/diacare.6.5.432

  4. Deren, J

    • A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care September 1983 6:463-467; doi:10.2337/diacare.6.5.463

  5. Djaldetti, M

    • Phagocytotic activity of monocytes from diabetic patients. Diabetes Care September 1983 6:479-482; doi:10.2337/diacare.6.5.479

  6. Dreher, M

    • Adherence to IDDM regimens: relationship to psychosocial variables and metabolic control. Diabetes Care September 1983 6:493-498; doi:10.2337/diacare.6.5.493

E

  1. Eisenbarth, G S

    • Immunotherapy of type I diabetes. Diabetes Care September 1983 6:521-523

  2. Elian, I

    • Phagocytotic activity of monocytes from diabetic patients. Diabetes Care September 1983 6:479-482; doi:10.2337/diacare.6.5.479

F

  1. Falchuk, K

    • A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care September 1983 6:463-467; doi:10.2337/diacare.6.5.463

  2. Feery, B J

    • Influenza immunization in adults with diabetes mellitus. Diabetes Care September 1983 6:475-478; doi:10.2337/diacare.6.5.475

  3. Finkelstein, J W

    • Twenty-four-hour cortisol profiles demonstrate exaggerated nocturnal rise in diabetic children. Diabetes Care September 1983 6:506-509; doi:10.2337/diacare.6.5.506

  4. Fishman, P

    • Phagocytotic activity of monocytes from diabetic patients. Diabetes Care September 1983 6:479-482; doi:10.2337/diacare.6.5.479

  5. Fonseca, V

    • Diarrhea and metformin in a diabetic clinic. Diabetes Care September 1983 6:472-474; doi:10.2337/diacare.6.5.472

  6. Fuhrmann, K

    • Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care September 1983 6:446-451; doi:10.2337/diacare.6.5.446

  7. Fukushima, D K

    • Twenty-four-hour cortisol profiles demonstrate exaggerated nocturnal rise in diabetic children. Diabetes Care September 1983 6:506-509; doi:10.2337/diacare.6.5.506

G

  1. Gal, P

    • Interference of new penicillins and cephalosporins with urine glucose monitoring tests. Diabetes Care September 1983 6:504-505; doi:10.2337/diacare.6.5.504

  2. Gicheru, K

    • Glycosylated serum albumin: an intermediate index of diabetic control. Diabetes Care September 1983 6:501-503; doi:10.2337/diacare.6.5.501

  3. Glasgow, R E

    • Adherence to IDDM regimens: relationship to psychosocial variables and metabolic control. Diabetes Care September 1983 6:493-498; doi:10.2337/diacare.6.5.493

  4. Goetz, F C

    • Urinary C-peptide as a measure of beta-cell function after a mixed meal in healthy subjects: comparison of four-hour urine C-peptide with serum insulin and plasma C-peptide. Diabetes Care September 1983 6:488-492; doi:10.2337/diacare.6.5.488

H

  1. Hagura, R

    • Chlorpropamide-induced hyponatremia: incidence and risk factors. Diabetes Care September 1983 6:468-471; doi:10.2337/diacare.6.5.468

  2. Hahn, H J

    • Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care September 1983 6:446-451; doi:10.2337/diacare.6.5.446

  3. Hahn von Dorsche, H

    • Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care September 1983 6:446-451; doi:10.2337/diacare.6.5.446

  4. Hampson, A W

    • Influenza immunization in adults with diabetes mellitus. Diabetes Care September 1983 6:475-478; doi:10.2337/diacare.6.5.475

  5. Hanning, I

    • The oral glucose tolerance test (OGTT): effect of rate of ingestion of carbohydrate and different carbohydrate preparations. Diabetes Care September 1983 6:441-445; doi:10.2337/diacare.6.5.441

  6. Hartman, L J

    • Influenza immunization in adults with diabetes mellitus. Diabetes Care September 1983 6:475-478; doi:10.2337/diacare.6.5.475

  7. Hayes, T M

    • Glycosylated serum albumin: an intermediate index of diabetic control. Diabetes Care September 1983 6:501-503; doi:10.2337/diacare.6.5.501

  8. Heine, R J

    • The oral glucose tolerance test (OGTT): effect of rate of ingestion of carbohydrate and different carbohydrate preparations. Diabetes Care September 1983 6:441-445; doi:10.2337/diacare.6.5.441

  9. Hildebrandt, P

    • The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration. Diabetes Care September 1983 6:459-462; doi:10.2337/diacare.6.5.459

  10. Hoogwerf, B J

    • Urinary C-peptide as a measure of beta-cell function after a mixed meal in healthy subjects: comparison of four-hour urine C-peptide with serum insulin and plasma C-peptide. Diabetes Care September 1983 6:488-492; doi:10.2337/diacare.6.5.488

I

  1. Ippoliti, A

    • A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care September 1983 6:463-467; doi:10.2337/diacare.6.5.463

  2. Irsigler, K

    • Diabetes treatment with implantable insulin delivery devices. Diabetes Care September 1983 6:527

J

  1. Jones, I R

    • Glycosylated serum albumin: an intermediate index of diabetic control. Diabetes Care September 1983 6:501-503; doi:10.2337/diacare.6.5.501

  2. Jones, M K

    • Glycosylated serum albumin: an intermediate index of diabetic control. Diabetes Care September 1983 6:501-503; doi:10.2337/diacare.6.5.501

  3. Jutzi, E

    • Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care September 1983 6:446-451; doi:10.2337/diacare.6.5.446

K

  1. Kadowaki, T

    • Chlorpropamide-induced hyponatremia: incidence and risk factors. Diabetes Care September 1983 6:468-471; doi:10.2337/diacare.6.5.468

  2. Kajinuma, H

    • Chlorpropamide-induced hyponatremia: incidence and risk factors. Diabetes Care September 1983 6:468-471; doi:10.2337/diacare.6.5.468

  3. Katz, S

    • Phagocytotic activity of monocytes from diabetic patients. Diabetes Care September 1983 6:479-482; doi:10.2337/diacare.6.5.479

  4. Keen, H

    • Meeting the problems of first-generation insulin infusion pumps: clinical trial of a new miniature infuser. Diabetes Care September 1983 6:452-458; doi:10.2337/diacare.6.5.452

  5. Klein, B

    • Phagocytotic activity of monocytes from diabetic patients. Diabetes Care September 1983 6:479-482; doi:10.2337/diacare.6.5.479

  6. Koivisto, V A

    • Postprandial blood glucose response to exercise in type I diabetes: comparison between pump and injection therapy. Diabetes Care September 1983 6:436-440; doi:10.2337/diacare.6.5.436

  7. Kream, J

    • Twenty-four-hour cortisol profiles demonstrate exaggerated nocturnal rise in diabetic children. Diabetes Care September 1983 6:506-509; doi:10.2337/diacare.6.5.506

  8. Kurtz, A B

    • A new approach to the treatment of nocturnal hypoglycemia using alpha-glucosidase inhibition. Diabetes Care September 1983 6:483-487; doi:10.2337/diacare.6.5.483

  9. Kuzuya, N

    • Chlorpropamide-induced hyponatremia: incidence and risk factors. Diabetes Care September 1983 6:468-471; doi:10.2337/diacare.6.5.468

L

  1. Laine, D

    • Urinary C-peptide as a measure of beta-cell function after a mixed meal in healthy subjects: comparison of four-hour urine C-peptide with serum insulin and plasma C-peptide. Diabetes Care September 1983 6:488-492; doi:10.2337/diacare.6.5.488

  2. Lebinger, T G

    • Twenty-four-hour cortisol profiles demonstrate exaggerated nocturnal rise in diabetic children. Diabetes Care September 1983 6:506-509; doi:10.2337/diacare.6.5.506

M

  1. Massey, E H

    • More on insulin-compatible materials. Diabetes Care September 1983 6:526

  2. Matta, L

    • Dear ol' mom. Diabetes Care September 1983 6:526-527

  3. McCallum, R W

    • A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care September 1983 6:463-467; doi:10.2337/diacare.6.5.463

  4. McCann, V J

    • Hemoglobinopathy in patients with diabetes mellitus: a complicating factor in the measurement of glycosylated hemoglobin. Diabetes Care September 1983 6:524

  5. McCaul, K D

    • Adherence to IDDM regimens: relationship to psychosocial variables and metabolic control. Diabetes Care September 1983 6:493-498; doi:10.2337/diacare.6.5.493

  6. McCue, J D

    • Interference of new penicillins and cephalosporins with urine glucose monitoring tests. Diabetes Care September 1983 6:504-505; doi:10.2337/diacare.6.5.504

  7. McCulloch, D K

    • A new approach to the treatment of nocturnal hypoglycemia using alpha-glucosidase inhibition. Diabetes Care September 1983 6:483-487; doi:10.2337/diacare.6.5.483

  8. Melton, L J

    • Sources of disparity in the spectrum of diabetes mellitus at incidence and prevalence. Diabetes Care September 1983 6:427-431; doi:10.2337/diacare.6.5.427

  9. Mier, A

    • Diarrhea and metformin in a diabetic clinic. Diabetes Care September 1983 6:472-474; doi:10.2337/diacare.6.5.472

  10. Mooradian, A D

    • The glycemic effect of different meals approximately isocaloric and similar in protein, carbohydrate, and fat content as calculated using the ADA exchange lists. Diabetes Care September 1983 6:432-435; doi:10.2337/diacare.6.5.432

  11. Morgan, L

    • The oral glucose tolerance test (OGTT): effect of rate of ingestion of carbohydrate and different carbohydrate preparations. Diabetes Care September 1983 6:441-445; doi:10.2337/diacare.6.5.441

  12. Mouradian, M

    • Diabetes mellitus and thyroid disease. Diabetes Care September 1983 6:512-520; doi:10.2337/diacare.6.5.512

N

  1. Nicol, D J

    • Hemoglobinopathy in patients with diabetes mellitus: a complicating factor in the measurement of glycosylated hemoglobin. Diabetes Care September 1983 6:524

  2. Nielsen, S L

    • The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration. Diabetes Care September 1983 6:459-462; doi:10.2337/diacare.6.5.459

  3. Noack, S

    • Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care September 1983 6:446-451; doi:10.2337/diacare.6.5.446

  4. Nuttall, F Q

    • The glycemic effect of different meals approximately isocaloric and similar in protein, carbohydrate, and fat content as calculated using the ADA exchange lists. Diabetes Care September 1983 6:432-435; doi:10.2337/diacare.6.5.432

O

  1. Ochi, J W

    • Sources of disparity in the spectrum of diabetes mellitus at incidence and prevalence. Diabetes Care September 1983 6:427-431; doi:10.2337/diacare.6.5.427

  2. Olsen, H W

    • A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care September 1983 6:463-467; doi:10.2337/diacare.6.5.463

  3. Owens, D R

    • Glycosylated serum albumin: an intermediate index of diabetic control. Diabetes Care September 1983 6:501-503; doi:10.2337/diacare.6.5.501

P

  1. Palumbo, P J

    • Sources of disparity in the spectrum of diabetes mellitus at incidence and prevalence. Diabetes Care September 1983 6:427-431; doi:10.2337/diacare.6.5.427

  2. Parker, S

    • The glycemic effect of different meals approximately isocaloric and similar in protein, carbohydrate, and fat content as calculated using the ADA exchange lists. Diabetes Care September 1983 6:432-435; doi:10.2337/diacare.6.5.432

  3. Pearson, R C

    • Interference of new penicillins and cephalosporins with urine glucose monitoring tests. Diabetes Care September 1983 6:504-505; doi:10.2337/diacare.6.5.504

  4. Pickup, J C

    • Meeting the problems of first-generation insulin infusion pumps: clinical trial of a new miniature infuser. Diabetes Care September 1983 6:452-458; doi:10.2337/diacare.6.5.452

  5. Proietto, J

    • Influenza immunization in adults with diabetes mellitus. Diabetes Care September 1983 6:475-478; doi:10.2337/diacare.6.5.475

R

  1. Rakatansky, H

    • A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care September 1983 6:463-467; doi:10.2337/diacare.6.5.463

  2. Reiher, H

    • Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care September 1983 6:446-451; doi:10.2337/diacare.6.5.446

  3. Rhodes, J B

    • A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care September 1983 6:463-467; doi:10.2337/diacare.6.5.463

  4. Ricci, D A

    • A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care September 1983 6:463-467; doi:10.2337/diacare.6.5.463

  5. Rich, S

    • Dear ol' mom. Diabetes Care September 1983 6:526-527

  6. Rothwell, D

    • Meeting the problems of first-generation insulin infusion pumps: clinical trial of a new miniature infuser. Diabetes Care September 1983 6:452-458; doi:10.2337/diacare.6.5.452

  7. Ryder, R E

    • Glycosylated serum albumin: an intermediate index of diabetic control. Diabetes Care September 1983 6:501-503; doi:10.2337/diacare.6.5.501

S

  1. Saenger, P

    • Twenty-four-hour cortisol profiles demonstrate exaggerated nocturnal rise in diabetic children. Diabetes Care September 1983 6:506-509; doi:10.2337/diacare.6.5.506

  2. Salen, G

    • A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care September 1983 6:463-467; doi:10.2337/diacare.6.5.463

  3. Santiago, J V

    • Dawn phenomenon and intensified therapy. Diabetes Care September 1983 6:525-526

  4. Schafer, L C

    • Adherence to IDDM regimens: relationship to psychosocial variables and metabolic control. Diabetes Care September 1983 6:493-498; doi:10.2337/diacare.6.5.493

  5. Sestoft, L

    • The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration. Diabetes Care September 1983 6:459-462; doi:10.2337/diacare.6.5.459

  6. Shakir, K M

    • Impotence as a presenting symptom of presumed prolactinoma in a patient with diabetes mellitus. Diabetes Care September 1983 6:510-511; doi:10.2337/diacare.6.5.510

  7. Skor, D A

    • Dawn phenomenon and intensified therapy. Diabetes Care September 1983 6:525-526

  8. Sutherland, I A

    • Meeting the problems of first-generation insulin infusion pumps: clinical trial of a new miniature infuser. Diabetes Care September 1983 6:452-458; doi:10.2337/diacare.6.5.452

T

  1. Tattersall, R B

    • A new approach to the treatment of nocturnal hypoglycemia using alpha-glucosidase inhibition. Diabetes Care September 1983 6:483-487; doi:10.2337/diacare.6.5.483

  2. Tronier, B

    • Postprandial blood glucose response to exercise in type I diabetes: comparison between pump and injection therapy. Diabetes Care September 1983 6:436-440; doi:10.2337/diacare.6.5.436

W

  1. White, N H

    • Dawn phenomenon and intensified therapy. Diabetes Care September 1983 6:525-526

  2. Williams, S

    • Glycosylated serum albumin: an intermediate index of diabetic control. Diabetes Care September 1983 6:501-503; doi:10.2337/diacare.6.5.501

  3. Woltanski, K P

    • Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care September 1983 6:446-451; doi:10.2337/diacare.6.5.446

  4. Wu, R

    • Twenty-four-hour cortisol profiles demonstrate exaggerated nocturnal rise in diabetic children. Diabetes Care September 1983 6:506-509; doi:10.2337/diacare.6.5.506

Y

  1. Yoshida, S

    • Chlorpropamide-induced hyponatremia: incidence and risk factors. Diabetes Care September 1983 6:468-471; doi:10.2337/diacare.6.5.468

Current Issue

  1. March 2010, 33 (3)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care